2015-2022 Biomaterials Discovery members
Academics / Project Manager / PostDocs / PhDs / Alumni / External Advisory board
Academics
Professor of Biomedical Surfaces, School of Pharmacy, Advanced Materials and Healthcare Technology
Morgan was Principal Investigator of this Programme Grant and lead of RC1: Moving from 2D to 3D Materials Discovery Methods.
Professor of Polymer Therapeutics, School of Pharmacy, Head of Molecular Therapeutics and Formulation Division
Cameron was Co-Investigator and lead of RC2: Systems Based Advanced Drug Delivery.
Professor of Tissue Engineering, School of Pharmacy, Regenerative Medicine and Cellular Therapies Division
Felicity was Co-Investigator and lead of RC3: Advanced Materials for 3D Stem Cell Differentiation and Regenerative Medicine.
Professor of Immunology & Immuno-bioengineering and Course Director for MSc in Immunology & Allergy, Faculty of Medicine & Health Sciences
Amir was Co-Investigator and lead of RC4: Advanced Materials for Medical Devices.
Professor of Advanced Drug Delivery and Tissue Engineering, School of Pharmacy, Regenerative Medicine and Cellular Therapies
Kevin was involved mainly in RC3.
Emeritus Professor of Biomedical Surface Chemistry, School of Pharmacy, Advanced Materials and Healthcare Technologies Division
Martyn was Co-Investigator and mainly involved in RC4.
Professor of Chemistry and Chemical Engineering, Faculty of Engineering
Derek was involved mainly in RC1 and 3.
Professor of Cancer Microenvironment, Faculty of Medicine & Health Sciences
Anna was involved mainly in RC2.
Professor; Head of Department of Stem Cell Biology, Faculty of Medicine & Health Sciences
Chris was Co-Investigator and mainly involved in RC3.
Professor of Multiphase Flow and Mechanics, Faculty of Engineering
Ricky was involved mainly in RC1 and 3.
Professor of Chemistry, Faculty of Science
Steve was involved mainly in RC2.
Professor of Molecular Microbiology, Faculty of Medicine & Health Sciences
Paul was involved mainly in RC4.
Professor of Innovative Manufacturing, Director - EPSRC Centre for Additive Manufacturing,Faculty of Engineering
Richard was Co-Investigator and mainly involved in RC1.
Professor of Materials Engineering, Faculty of Engineering
Christopher was involved mainly in RC1.
Professor in Stem Cell Glycobiology,
Faculty of Medicine & Health Sciences.
Cathy was involved mainly in RC3.
Professor of Biophysics, Director of Research and Knowledge Exchange,
Faculty of Science
Phil was involved mainly in RC1.
Assistant Professor in Analytical Bioscience,
Shool of Pharmacy.
Hyun was involved mainly in RC1.
Project Manager
EPSRC Programme Grant Project Manager
Faculty of Science
Post Docs
Postdoctoral Research Fellow: School of Pharmacy
Chester joined the project in 2021 working on combinatorial screening of biomaterial surface chemistry and topography in RC1.
Postdoctoral Research Fellow: School of Pharmacy, Advanced Materials and Healthcare Technologies Division.
Le joined the project in 2018 working on creating 3D architecture libraries with two photon polymerisation in RC1.
Senior Research Data Scientist: Faculty of Information Services
Postdoctoral Research Fellow: Faculty of Medicine & Health Sciences
Aishah joined the project in 2018 working on cardiomyocyte maturation in RC3.
Postdoctoral Research Fellow, Faculty of Engineering
Adam joined the project in 2017 working on making polymer particles from microfluidics in RC1.
Postdoctral Research Fellow in Biomaterials Development and Additive Manufacturing
Robert joined the grant in 2020 and works on differentiation of human mesenchymal stem cells to bone in RC3.
Postdoctoral Research Fellow: School of Life Sciences
Ana joined the project in 2018 working on bacterial attachment and polymicrobial interactions in RC4.
Postdoctoral Research Fellow, Medicine & Health Sciences
Arsalan joined the project in 2016 as a PhD student and continues as a Post Doc working on Developing immune instructive niches to promote healing and suppress fibrosis, mainly associated with RC4.
Postgraduate students
PhD student, School of Pharmacy
Main Supervisor: Phil Williams
Charlotte joined the project in 2017 working on Micropipette manipulation for nanoparticle production and characterization in biomaterials discovery, mainly associated with RC1.
PhD Student, Medicine & Health Sciences
Main supervisor Paul Williams
Kiril joined the project in 2016 working on Exploiting 3D synthetic bacterial communities to investigate virulence and antibiotic resistance, mainly associated with RC4.
PhD student, Medicine and Health Sciences
Main supervisor, Anna Grabowska
Eduardo joined the project in 2017 working on screening combinatorial materials microarrays to identify inducers of epithelial-mesenchymal transition, mainly associated with RC2.
PhD student, Medicine and Health Sciences
Main supervisor Cathy Merry
Jamie joined the project in 2017 working on matrix-inspired biomaterials for cell phenotype control, mainly associated with RC3.
PhD student, School of Pharmacy
Main Supervisor: Phil Williams
Leonardo joined the project in 2018 working on computational approaches to determining biomaterial design rules, mainly associated with RC1.
PhD student, School of Pharmacy
Main Supervisors: Lisa White, Andrew Bennett, Jing Yang and Morgan Alexander
Elisa's work investigated liver extracellular matrix (ECM) hydrogels as 3D scaffold for the support, growth and differentiation of human progenitor liver cells for the development of a liver in-vitro model.
Alumni
Previously a PostDoctoral Research Fellow in the School of Pharmacy working on Determining Biomaterial Design Rules in RC1.
We said farewell to Paulius in November 2018. He is now a Postdoc fellow at AstraZeneca, Sweden and working on a 2nd PhD.
Previously a Postdoctoral
Research Fellow: School of Pharmacy, Stem Cell Biology.
Mahetab left the grant in 2020, and now works as a University Academic Fellow in Predictive Disease Models at the University of Leeds.
Previously a PostDoctoral Research Fellow in the Faculty of Engineering, working on making polymer particles from microfluidics in RC1.
We said farewell to Simon in November 2017, and he now works as a Senior Research Scientist at Promethean Particles Ltd.
Karl Firth
Previously a PostDoctoral Research Fellow in the Faculty of Medicine & Health Sciences, working on cardiomyocyte maturation in RC3.
We said farewell to Karl in November 2017 and he has taken up a position with Clyde Biosciences.
Benoit Couturaud
Previously a PostDoctoral Research Fellow: School of Pharmacy, Molecular Therapeutics and Formulation Division working on polymers for drug delivery in RC2.
We said farewell to Benoit in August 2016
and he has taken up a Marie Curie Fellowship at The University of Warwick with
Professor Rachel O’Reilly and Kristopher Thurecht (The University of Queensland).
Previously a PostDoctoral Research Fellow in the School of Pharmacy, working on combinatorial screening of biomaterial surface chemistry and topography in RC1.
We said farewell to Britta at the end of January 2018. She is currently working as a Marketing Manager for _fbeta GmbH in Berlin, Germany.
Blessing Mukonoweshuro
Previously a PostDoctoral Research Fellow in Immunology and Biomaterials, Faculty of Medicine & Health Sciences, working on immunology in RC4.
We said farewell to Blessing in November 2017 and he has taken up a position as an Intellectual Property and Innovation Officer at the Quadram Institute in Norwich.
Marta Alvarez Paino
Previously a PostDoctoral Research Fellow in the School of Pharmacy, working on polymer microparticles for regenerative medicine in RC3.
We said farewell to Marta in July 2018, and she is working in a pharmaceutical
company in Spain.
Previously a Postdoctoral Research Fellow: School of Pharmacy, Molecular Therapeutics and Formulation Division working on polymers for drug delivery in RC2.
We said farewell to Nishant in September 2018 and he has taken up a position at Laboratoire des Systèmes Complexes Hors Équilibre, University of Strasbourg, France.
Previously a PostDoctoral Research Fellow: School of Life Sciences working on microbiology in RC4.
We said farewell to Manuel in September 2018. He has taken up a Research Fellow position at the University of Nottingham.
Previously Postdoctoral Research Fellow, School of Pharmacy.
Thais left the grant in 2020 after working as part of RC2, researching drug treatments for triple negative breast cancer and now has a CAPES/Print international fellowship at Universidade Federal do Mato Grosso do Sul (UFMS), Brazil.
Previously a PostDoctoral Research Fellow: School of Pharmacy, Molecular Therapeutics and Formulation Division.
Amanda left in March 2019 after working in RC2 and now works at the University of Birmingham as a Senior Research Fellow and PERCAT rep for the School of Chemistry.
Previously a Postdoctoral Research Fellow.
Hassan's work Investigated the impact of some known M1 and M2 biased polymers on in vitro liver fibrosis model. He started a post-doctral fellow role in the School of Life Sciences in 2021.
Previously Postdoctoral Research Fellow, School of Pharmacy.
Laurence left the project in 2020 after working as part of RC1 on combinatorial screening of biomaterial surface chemistry and topography.
Previously a PhD Student, Faculty of Medicine & Health Sciences.
Jordan came to the end of his PhD in 2020 and now works in Australia at the Victor Chang Cardiac Research Institute in Sydney.
Previously a Postdoctoral Research Fellow: School of Life Sciences.
Matt joined the project in 2017 working on immunology in RC4 and left us in 2021 to work at Aston University as a Technology Transfer Manager.
Postdoctoral Research Fellow: School of Pharmacy
Patricia joined the grant in 2019 and worked as part of RC2, researching drug treatments for triple negative. She left to work in the same field at Astra Zeneca in 2021.
Postdoctoral Research Fellow: School of Pharmacy.
Scarlett joined the project in 2020 worked on combinatorial screening of biomaterial surface chemistry and topography in RC1.
She is currently working on a related UKRI Covid-19 project at the University of Nottingham.
PhD student, School of Pharmacy
Main supervisor Hyun Kim
Joris joined the project in 2017 working on developing mass spectrometry strategies for examination of cellular responses in media and on complex surfaces, mainly associated with RC1. He attainded his PhD in 2021 and took up a Post Doctral position at Radboud University, Netherlands.
Alessandra joined the project in 2016 and worked on Multi-Component Polymerization (MCP) Reactions for Biomedical Materials, mainly associated with RC2. Alessandra gained her PhD in 2020 and started work as R&D associate at Reckitt Benckiser, Italy.
PhD Student, School of Chemistry
Main supervisor Steve Howdle
Dara joined the project in 2016 and worked on new and renewably sourced sustainable functional degradable polymers, mainly associated with RC2.
Dara attainded her PhD in 2020 and is currently working as a Business Development and Operations Associate at Exactmer, London.
Postdoctoral Research Fellow: School of Pharmacy
Robert joined the grant in 2019 and worked as part of RC2, researching drug treatments for triple negative breast cancer. Robert took up a new role at the University of Nottingham in 2021 linked to the EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers.
PhD Student, Faculty of Engineering
Main supervisor Derek Irvine
Valentina joined the project in 2016 working on Continuous Sustainable Synthesis of Polymeric Resins for use in the Construction of 3D structures. Initially she was mainly associated with RC2 but increasingly linked to RC3. Valentina passed her PhD in 2021 and took up a post doctoral position in the Faculty of Engineering, here at the University of Nottingham.
Postdoctoral Research Fellow, School of Pharmacy
Francesco joined the project in 2016 as a PhD student and continued as a Post Doc working on Novel polymer microparticles and their influence on mesenchymal stem cell behaviour, mainly associated with RC3. Francesco returned to Italy in 2021.
External Advisory Board
Dave Grainger, University of Utah
Karen Davies, EPSRC Representative
Brian Henry, Pfizer
Joe De Sousa, AstraZeneca
Mark Bradley, University of Edinburgh
Rachel O'Reilly, University of Birmingham
David Farrar, Xiros
Robert Quirk, Locate Therapeutics